CAMP4 Therapeutics CorporationCAMPNASDAQ
Loading
Year-over-year operating cash flow growth rate
| Period | Value |
|---|---|
| Q4 2025 | 156.10% |
| Q3 2025 | -8.45% |
| Q2 2025 | 27.60% |
| Q1 2025 | -26.56% |
| Q4 2024 | -16.46% |
| Q3 2024 | 27.87% |
| Q2 2024 | -20.60% |
| Q1 2024 | 5.43% |
| Q4 2023 | -79.78% |
| Q3 2023 | -119.93% |
| Q2 2023 | -173.14% |
| Q1 2023 | -128.46% |
| Q4 2022 | 137.87% |
| Q3 2022 | 34.89% |
| Q2 2022 | -106.48% |
| Q1 2022 | -5.51% |
| Q4 2021 | -168.81% |
| Q3 2021 | 13198.72% |
| Q2 2021 | -98.16% |
| Q1 2021 | -58.50% |
| Q4 2020 | 24.96% |
| Q3 2020 | 37.69% |
| Q2 2020 | -27.91% |
| Q1 2020 | 123.76% |
| Q4 2019 | -28.79% |
| Q3 2019 | 193.16% |
| Q2 2019 | -1472.80% |
| Q1 2019 | -103.13% |
| Q4 2018 | 90.17% |
| Q3 2018 | -80.85% |
| Q2 2018 | 278.68% |
| Q1 2018 | -64.07% |
| Q4 2017 | -9.48% |
| Q3 2017 | 130.12% |
| Q2 2017 | 81.77% |
| Q1 2017 | 1152.82% |
| Q4 2016 | -95.64% |
| Q3 2016 | 32.11% |
| Q2 2016 | -12.67% |
| Q1 2016 | 4.61% |